Endothelin receptors in human coronary artery and aorta

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 986-992

  Bacon, C R ^a   Davenport, A P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endothelin receptors; ET(A) receptors; ET(B) receptors; Human aorta; Human coronary artery; Sarafotoxin; Vascular smooth muscle

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; N (HEXAHYDRO 1 AZEPINYLCARBONYL)LEUCYL(1 METHYL DEXTRO TRYPTOPHYL) DEXTRO TYROSINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; SARAFOTOXIN S6B;

ADULT; AORTA; AORTA MEDIA; ARTERY MEDIA; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CORONARY ARTERY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0029865869     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15292.x     Document Type: Article

References (31)

1. BACON, C.R., MORRISON, J.J., O'REILLY, G., CAMERON, I.T. & DAVENPORT, A.P. (1995). ETA and ETB receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. J. Endocrinol., 144, 127-134.
2. BAX, W.A., BOS, E. & SAXENA, P.R. (1993a). Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur. J. Pharmacol., 239, 267-268.
3. BAX, W.A., BRUINVELS, A.T., VAN-SUYLEN, R.J., SAXENA, P.R. & HOYER, D. (1993b). Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn-Schmied. Arch. Pharmacol., 348, 403-410.
4. BODELSSON, G. & STJERNQUIST, M. (1993). Characterization of endothelin receptors and localization of 125I-endothelin-1 binding sites in human umbilical artery. Eur. J. Pharmacol., 249, 299-305.
5. 8 receptors. Br. J. Pharmacol., 112, 1251-1257.
6. CLOZEL, M., BREU, V., BURRI, K., CASSEL, J.-M., FISCHLI, W., GRAY, G.A., HIRTH, G., LOFFLER, B.-M., MULLER, M., NEIDHART, W. & RAMUZ, H. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature, 365, 759-761.
7. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LOFFLER, B.-M., BURRI, K., CASSAL, J.M., HIRTH, G., MULLER. M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
8. CRISTOL, J.-P., WARNER, T.D., THIEMERMANN, C. & VANE, J.R. (1993). Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br. J. Pharmacol., 108, 776-779.
9. A receptors. Br. J. Pharmacol., 111, 4-6.
10. A receptors in human kidney which localizes to renal vasculature. Br. J. Pharmacol., 113, 1303-1310.
11. DAVENPORT, A.P. & MAGUIRE, J.J. (1994). Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans? Trends Pharmacol. Sci., 15, 9-11.
12. A subtype. Br. J. Pharmacol., 114, 1110-1116.
13. B receptors in human vascular smooth muscle. J. Cardiovasc. Pharmacol., 22(S8), 22-25.
14. DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A., 85, 9797-9800.
15. 11,15] Ac-endothelin-1(6-21) in conscious rats. Br. J. Pharmacol., 112, 477-486.
16. GODFRAIND, T. (1993). Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol., 110, 1201-1205.
17. HARRISON, V.J., RANDRIANTSOA, A. & SCHOEFFTER, P. (1992). Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br. J. Pharmacol., 105, 511-513.
18. B) receptors. Life Sci., 51, 47-52.
19. B in human kidney. Kidney Int., 44, 36-42.
20. KLOOG, Y. & SOKOLOVSKY. (1989). Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol. Sci., 10, 212-214.
21. LERMAN, A., EDWARDS, B.S., HALLETT, J.W., HEUBLEIN, D.M., SANDBERG, S.M. & BURNETT, J.C. (1991). Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. New Engl. J. Med., 325, 991-1001.
22. A receptors. J. Hyperten., 12, 675-680.
23. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol., 115, 191-197.
24. MAGUIRE, J.J., KUC, R.E., O'REILLY, G. & DAVENPORT, A.P. (1994b). Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br. J. Pharmacol., 113, 49-54.
25. 125I]S6b binding with subnanomolar affinity but is a more potent antagonist of S6b vasoconstriction in human isolated blood vessels. Br. J. Pharmacol., 114, 75P.
26. MCPHERSON, G.A. (1985). Analysis of radioligand binding experiments. J. Pharmacol. Methods, 14, 213-228.
27. MOLENNAR, P., O'REILLY, G., SHARKEY, A., KUC, R.E., HARDING, D.P., PLUMPTON, C., GRESHAM, G.A. & DAVENPORT, A.P. (1993). Characterization and localization of endothelin receptor sub-types in the human atrioventricular conducting system and myocardium. Circ. Res., 72, 526-538.
28. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem., 107, 220-239.
29. B-selective agonist, displays species differences in its binding characteristics. Neuropeptides, 28, 191-196.
30. OPGAARD, O.S., ADNER, M., GULBENKIAN, S. & EDVINSSON, L. (1994). Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J. Cardiovasc. Pharmacol., 23, 576-583.
31. A receptors in the heart. Br. J. Pharmacol., 114, 297-302.